DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol ▲ | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0476089 | Endometrial Carcinoma | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0341106 | Eosinophilic esophagitis | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0026850 | Muscular Dystrophy | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0024121 | Lung Neoplasms | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C1306459 | Primary malignant neoplasm | PRG3 | 10394 | proteoglycan 3, pro eosinophil major basic protein 2 | Q9Y2Y8 |
C0006118 | Brain Neoplasms | PRG3 | 10394 | proteoglycan 3, pro eosinophil major basic protein 2 | Q9Y2Y8 |
C0038454 | Cerebrovascular accident | PRG3 | 10394 | proteoglycan 3, pro eosinophil major basic protein 2 | Q9Y2Y8 |
C0006826 | Malignant Neoplasms | PRG3 | 10394 | proteoglycan 3, pro eosinophil major basic protein 2 | Q9Y2Y8 |
C0280634 | Adult Acute Monocytic Leukemia | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0020456 | Hyperglycemia | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0017636 | Glioblastoma | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0025517 | Metabolic Diseases | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0684249 | Carcinoma of lung | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0678222 | Breast Carcinoma | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0600139 | Prostate carcinoma | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0919267 | ovarian neoplasm | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C2931822 | Nasopharyngeal carcinoma | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0028754 | Obesity | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C1306459 | Primary malignant neoplasm | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0524620 | Metabolic Syndrome X | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C1621958 | Glioblastoma Multiforme | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0006826 | Malignant Neoplasms | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0007115 | Malignant neoplasm of thyroid | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0006142 | Malignant neoplasm of breast | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024